Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 181
Filtrar
Mais filtros

Intervalo de ano de publicação
2.
J Am Pharm Assoc (2003) ; 58(5): 505-514.e2, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30076098

RESUMO

OBJECTIVES: A major policy to increase immunization rates against infectious diseases in the United States has included pharmacy-based immunization services. We aimed to determine the impact of pharmacy-based immunization services on the likelihood of adult influenza and pneumococcal immunization. DESIGN: National individual-level immunization data were merged with pharmacy-level data on the availability of immunization services for 8466 pharmacies from a national pharmacy chain. County-level variation in availability of vaccines from 2006 to 2010 was used to characterize exposure to immunization services. We used a longitudinal logistic regression model to estimate the impact of pharmacy-based immunization services on the outcomes of interest. SETTING AND PARTICIPANTS: We conducted the main analysis in the U.S. adult population. We conducted subgroup analyses of high-risk populations, including people 65 years of age or older. OUTCOME MEASURES: Odds of being immunized for influenza or pneumococcal disease after exposure to the service compared with before the service while controlling for existing trends in immunization rate growth and other confounders. RESULTS: Each additional year of exposure to pharmacy-based immunization services was associated with a 1.023 (CI 1.012-1.034) greater odds of reporting an influenza immunization and a 1.016 (CI 1.006-1.027) greater odds of reporting a pneumococcal immunization. Five years after national implementation, we estimate that 6.2 million additional influenza immunizations and 3.5 million additional pneumococcal immunizations are attributable to pharmacy-delivered immunization services each year. Subgroup analyses further indicate that the policy increased the odds of immunization for both diseases over time among adults 65 years of age or older (influenza odds ratio [OR] 1.025, CI 1.013-1.038; and pneumococcal OR 1.026, CI 1.010-1.042). CONCLUSION: Pharmacy-based immunization services increased the likelihood of immunization for influenza and pneumococcal diseases, resulting in millions of additional immunizations in the United States.


Assuntos
Serviços Comunitários de Farmácia/organização & administração , Programas de Imunização/organização & administração , Imunização/legislação & jurisprudência , Farmácias/organização & administração , Farmacêuticos/organização & administração , Adolescente , Adulto , Idoso , Feminino , Humanos , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/imunologia , Influenza Humana/imunologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Infecções Pneumocócicas/imunologia , Estados Unidos , Vacinação/legislação & jurisprudência , Adulto Jovem
3.
Med Law Rev ; 25(1): 99-114, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-28177508

RESUMO

In 2005, China introduced an administrative no-fault one-time compensation scheme for adverse events following immunization (AEFI). The scheme aims to ensure fair compensation for those injured by adverse reactions following immunization. These individuals bear a significant burden for the benefits of widespread immunization. However, there is little empirical evidence of how the scheme has been implemented and how it functions in practice. The article aims to fill this gap. Based on an analysis of the legal basis of the scheme and of practical compensation cases, this article examines the structuring, function, and effects of the scheme; evaluates loopholes in the scheme; evaluates the extent to which the scheme has achieved its intended objectives; and discusses further development of the scheme.


Assuntos
Compensação e Reparação , Imunização/efeitos adversos , Imunização/legislação & jurisprudência , China , Humanos
4.
J Med Philos ; 41(5): 461-79, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27473409

RESUMO

In Unfit for the Future, Ingmar Persson and Julian Savulescu present a sophisticated argument in defense of the imperative of moral enhancement. They claim that without moral enhancement, the future of humanity is seriously compromised. The possibility of ultimate harm, caused by a dreadful terrorist attack or by a final unpreventable escalation of the present environmental crisis aggravated by the availability of cognitive enhancement, makes moral enhancement a top priority. It may be considered optimistic to think that our present moral capabilities can be successfully improved by means of moral education, moral persuasion, and fear of punishment. So, without moral enhancement, drastic restrictions on human freedom would become the only alternative to prevent those dramatic potential outcomes. In this article, I will try to show that we still have reason to be less pessimistic and that Persson & Savulescu's arguments are fortunately unconvincing.


Assuntos
Desenvolvimento Moral , Filosofia Médica , Responsabilidade Social , Temas Bioéticos , Liberdade , Direitos Humanos , Humanos , Imunização/ética , Imunização/legislação & jurisprudência , Princípios Morais , Autonomia Pessoal
5.
J Sch Nurs ; 32(4): 246-57, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26699951

RESUMO

Students in Vermont with incomplete or undocumented immunization status are provisionally admitted to schools and historically had a calendar year to resolve their immunization status. The process of resolving these students' immunization status was challenging for school nurses. We conducted a school-based quality improvement effort to increase student compliance with Vermont immunization regulations using a collaborative learning approach with public health school liaisons and school nurses from public schools to reduce provisional admittance in 2011-2012. Strategies included using a tracking system, accessing the immunization registry, promoting immunization importance, tracking immunization plans, and working with medical homes to update records. Participating school nurses observed decreases in the number of provisionally admitted students, although this reduction was not significantly different than matched comparison schools. We also found the number of provisionally admitted students fluctuated throughout the year and resolving the immunization status of New Americans and exchange students required special attention. Our approach supports the coordinated school health model and demonstrates the critical role school nurses play in improving population health outcomes.


Assuntos
Comportamentos Relacionados com a Saúde , Programas de Imunização/estatística & dados numéricos , Imunização/legislação & jurisprudência , Imunização/estatística & dados numéricos , Serviços de Saúde Escolar/estatística & dados numéricos , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Programas de Imunização/legislação & jurisprudência , Masculino , Serviços de Saúde Escolar/legislação & jurisprudência , Serviços de Enfermagem Escolar , Vermont
6.
Br J Nurs ; 25(19): 1076-1077, 2016 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-27792440

RESUMO

In this article Richard Griffith, Senior Lecturer in Health Law at Swansea University, reviews the involvement and approach of the Courts in cases of hotly disputed immunisation.


Assuntos
Comportamento de Escolha , Vacina contra Sarampo-Caxumba-Rubéola/uso terapêutico , Sarampo/prevenção & controle , Pais , Vacinação/legislação & jurisprudência , Criança , Surtos de Doenças/prevenção & controle , Humanos , Imunização/legislação & jurisprudência , Sarampo/epidemiologia , Reino Unido
8.
Am J Public Health ; 104(9): e3-6, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25033149

RESUMO

Exemptions from childhood immunizations required for school entry have continued to increase among California kindergartners, and exemptions show spatial clustering within the state. A 2014 change in California's school-entry vaccine exemption law requires parents filing for an exemption to submit signed documents from a health care provider. However, the evidence presented here suggests that the policy change will probably not be sufficient to reverse the growing trend in vaccine refusals.


Assuntos
Política de Saúde , Imunização/legislação & jurisprudência , Instituições Acadêmicas/legislação & jurisprudência , Vacinas/administração & dosagem , California , Análise por Conglomerados , Humanos , Prevalência
11.
Br J Community Nurs ; 18(11): 545-7, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24471227

RESUMO

Following an outbreak of measles in Swansea in 2013, the U.K. courts were asked to order the immunisation of children after an unresolved dispute over the merits of the vaccination between the parents of two children. This article reviews the involvement and approach of the courts in cases of hotly disputed immunisation and argues that going to litigation and obtaining a court order is no guarantee that the vaccination will be given to the child.


Assuntos
Dissidências e Disputas/legislação & jurisprudência , Imunização/legislação & jurisprudência , Vacina contra Sarampo-Caxumba-Rubéola , Pais , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Adolescente , Criança , Feminino , Humanos , Reino Unido
12.
J Infect Dis ; 206(7): 989-92, 2012 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-22936834

RESUMO

All 50 US states allow medical exemptions from school entry immunization requirements. The extent to which medical exemptions are granted and the relationship with ease of obtaining these exemptions has not previously been examined in detail. We evaluated counts and rates of state-level medical exemptions to kindergarten entry requirements over 7 school years (2004-2005 through 2010-2011). During this period, 0.26%-0.41% of enrolled children received medical exemptions. In states with easier medical exemption criteria, medical exemption rates were significantly higher (adjusted incidence rate ratio: 6.4 [95% confidence interval: 2.7-15.6]). Routine evaluation of medical exemption rates is needed to ensure their appropriate use.


Assuntos
Imunização/legislação & jurisprudência , Pré-Escolar , Política de Saúde , Humanos , Imunização/estatística & dados numéricos , Análise de Regressão , Critérios de Admissão Escolar , Estados Unidos
13.
Front Public Health ; 11: 1211976, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37608980

RESUMO

Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault programs have been established to compensate individuals for vaccine-related injuries. China also established a vaccine injury compensation system with its own unique characteristics. The Vaccine Administration Law was promulgated in 2019 to establish a compensation system for those who experience adverse reactions following immunization; nevertheless, the compensation system is imperfect. Even when the applicable terms are applied to deal with vaccine-related injuries, some issues remain, such as unreasonable diagnosis and evaluation procedures for adverse reactions, excessively strict standards regarding proof and inconsistent compensation standards across the country. Therefore, to provide effective compensation for vaccine recipients, it is important to clarify the standards of proof and establish a sensible vaccine injury compensation system that includes Corona Virus Disease 2019 vaccine-injury compensation.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Compensação e Reparação , Humanos , China , COVID-19/prevenção & controle , Vacinas contra COVID-19/efeitos adversos , Imunização/efeitos adversos , Imunização/legislação & jurisprudência , Vacinação/efeitos adversos
15.
Med Pr ; 63(2): 251-4, 2012.
Artigo em Polonês | MEDLINE | ID: mdl-22779331

RESUMO

After the European Union accession in 2004, Poland has been perceived by foreigners as an attractive destination of their migration, and also as a popular transit country for people going further to the Western Europe countries. The Nofer Institute of Occupational Medicine is involved in the implementation of the international project PROMOVAX (Promote Vaccinations among Migrant Populations in Europe). The objective of the project is to promote immunizations among migrant populations in Europe. This article presents the up-to-date legal regulations that are effective in Poland, taking into account their relevance to the issue of vaccinations in migrant population. The analysis of the Polish legislation concerning this problem shows that there are no specific regulations addressed to migrant population staying in our country. This issue seems to be popular in the European Union, where immunization of migrants is given high priority. From the point of view of health care professionals it is important to be aware of the fact that EU open borders favor the increased flow of people between countries. The scale of migration from outside the EU to its member states also contributes to the increase in potential contacts between health care workers and migrants working in Poland.


Assuntos
Controle de Doenças Transmissíveis/legislação & jurisprudência , Imunização/legislação & jurisprudência , Doenças Profissionais/prevenção & controle , Serviços de Saúde do Trabalhador/legislação & jurisprudência , Migrantes/legislação & jurisprudência , Migrantes/estatística & dados numéricos , Vacinação/legislação & jurisprudência , União Europeia , Humanos , Esquemas de Imunização , Medicina do Trabalho/legislação & jurisprudência , Polônia
16.
Adv Neonatal Care ; 11(3): 173-9, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21730910

RESUMO

With few exceptions, it is currently recommended that all premature infants should receive routine childhood vaccines at the same chronologic age as term infants. Thus, neonatal nurses need to stay current on the recommendations for immunizations commonly used in the NICU setting. It is important for nurses to provide information that is reliable and verifiable with scientific evidence to the parents.


Assuntos
Imunização , Recém-Nascido Prematuro , Anticorpos Monoclonais Humanizados/administração & dosagem , Antivirais/administração & dosagem , Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Vacinas Anti-Haemophilus/administração & dosagem , Vacinas contra Hepatite B/administração & dosagem , Humanos , Imunização/efeitos adversos , Imunização/legislação & jurisprudência , Imunização/enfermagem , Esquemas de Imunização , Lactente , Recém-Nascido , Vacinas contra Influenza/administração & dosagem , Unidades de Terapia Intensiva Neonatal , Palivizumab , Vacinas Pneumocócicas/administração & dosagem , Vacina Antipólio de Vírus Inativado/administração & dosagem , Guias de Prática Clínica como Assunto , Estados Unidos
17.
Med Anthropol Q ; 25(4): 436-56, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22338289

RESUMO

Vaccination anxieties grew into a public health issue during the 2008 failed measles and rubella immunization campaign in Ukraine. Here I explore how health care providers bend official immunization policies as they navigate media scares about vaccines, parents' anxieties, public health officials' insistence on the need for vaccination, and their own sense of expertise and authority. New hierarchies are currently being renegotiated, and I follow health care providers as they attempt to parcel out their new position in the Ukrainian society and beyond. Public health control is reframed in a postsocialist context as a condition of acceptance into the European community as a sanitary democracy, and a contestation point between citizens and state. I untangle how relationships between citizens and states shape the construction of medical risk.


Assuntos
Promoção da Saúde , Programas de Imunização/legislação & jurisprudência , Imunização/legislação & jurisprudência , Imunização/psicologia , Aceitação pelo Paciente de Cuidados de Saúde , Humanos , Sarampo/epidemiologia , Sarampo/prevenção & controle , Vacina contra Sarampo/administração & dosagem , Sistemas Políticos , Rubéola (Sarampo Alemão)/epidemiologia , Rubéola (Sarampo Alemão)/prevenção & controle , Vacina contra Rubéola/administração & dosagem , Ucrânia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA